Medtronic Bladder Control Interstim Systems | Adult & Pediatric Urology

Medtronic Bladder Control Interstim Systems

When lifestyle changes and medications fail, Medtronic Bladder Control Interstim Systems can help. This therapy is simple and discreet, and it delivers the kind of relief that lets you enjoy the activities you love without a second thought.

Medtronic Bladder Control Interstim Systems

  • Targets the nerves that control your bladder to help it function normally again
  • 85% of people using the InterStim™ system achieved success in the first year
  • 3X greater improvements in quality of life compared to medications6=
  • Lets you see if it works before you and your doctor decide
  • Allows you to get full-body MRI scans if you need them
  • Hundreds of thousands of people have experienced relief with this safe, FDA-approved, and minimally invasive therapy

Interstim Systems

Medtronic bladder control therapy delivered by the InterStim™ systems offers recharge-free and rechargeable options, so you can choose the right one for your lifestyle.

  • The recharge-free InterStim™ II system may be best for most people because it’s simple, convenient, and low maintenance.
  • The rechargeable InterStim™ Microsystem is smaller, lasts longer, and requires regular recharging sessions.

INTERSTIM™ II SYSTEM

Features

  • Recharge-free battery
  • Battery Life: Approximately 5-6 years§
  • Device Size: 12.5 cm3
  • No routine maintenance
  • SureScan™ MRI technology allows 1.5 and 3T full-body scans

Components/Accessories

  • Smart programmer, communicator

INTERSTIM™ MICRO SYSTEM

 

Features

  • Rechargeable battery with OverdriveTM technology
  • Battery Life: up to 15 years
  • Device Size: 2.8 cm3
  • Weekly recharging of 20 minutes||
  • SureScan™ MRI technology allows 1.5 and 3T full-body scans

Components/Accessories

  • Smart programmer, communicator, recharger, charging dock, recharging belt

Lasting Relief

Medtronic bladder control therapy delivered by the InterStim™ II system provides life-changing relief. And the InterStim™ Microsystem is designed to deliver the same effective results.

  • 84% satisfaction among those who use it7,¶
  • 76% of people achieved success at 6 months compared to 49% who used medications4,# 
  • The only OAB therapy that provides better relief than medications4,8

The most common adverse events experienced during clinical studies included pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause the return of symptoms.

MEDTRONIC BLADDER CONTROL THERAPY DELIVERED BY THE NURO™ SYSTEM

Medtronic bladder control therapy delivered by the NURO™ system helps you live with less worry and more confidence. By restoring bladder function, it puts you on a path to fewer trips to the bathroom, and more of the activities you enjoy.

  • Targets the tibial nerve to help you regain control of your bladder
  • Does not cause unpleasant side effects like many oral medications can10
  • Does not require self-catheterization, unlike injectable medications8
  • Helps you live with less worry and more confidence

The NURO™ system only treats the symptoms of OAB, not retention.

The most common side effects of PTNM are temporary and include mild pain or skin inflammation at or near the stimulation site. Click here for more information. 

Talk with our doctors about diagnosis and treatment information today to see if Medtronic Bladder Control InterStim Systems is right for you.

ADULT PEDIATRIC UROLOGY & UROGYNECOLOGY

The attentive, compassionate physicians, providers, and staff at Adult Pediatric Urology & Urogynecology are committed to providing innovative, quality patient care in our state-of-the-art facility.

From screening and prevention to treatment and recovery, we will be there for you. Our team of dedicated physicians has been serving residents of Nebraska, Iowa, and South Dakota for more than 25 years.

Contact us today.

 

Comments are closed.